Development and validation of a comprehensive patient-specific quality assurance program for a novel stereotactic radiation delivery system for breast lesions
JournalJournal of Applied Clinical Medical Physics
PublisherJohn Wiley and Sons Ltd
MetadataShow full item record
AbstractPurpose: The GammaPod is a dedicated prone breast stereotactic radiosurgery (SRS) machine composed of 25 cobalt‐60 sources which rotate around the breast to create highly conformal dose distributions for boosts, partial‐breast irradiation, or neo‐adjuvant SRS. We describe the development and validation of a patient‐specific quality assurance (PSQA) system for the GammaPod. Methods: We present two PSQA methods: measurement based and calculation based PSQA. The measurements are performed with a combination of absolute and relative dose measurements. Absolute dosimetry is performed in a single point using a 0.053‐cc pinpoint ionization chamber in the center of a polymethylmethacrylate (PMMA) breast phantom and a water‐filled breast cup. Relative dose distributions are verified with EBT3 film in the PMMA phantom. The calculation‐based method verifies point doses with a novel semi‐empirical independent‐calculation software. Results: The average (± standard deviation) breast and target sizes were 1263 ± 335.3 cc and 66.9 ± 29.9 cc, respectively. All ion chamber measurements performed in water and the PMMA phantom agreed with the treatment planning system (TPS) within 2.7%, with average (max) difference of –1.3% (−1.9%) and −1.3% (−2.7%), respectively. Relative dose distributions measured by film showed an average gamma pass rate of 97.0 ± 3.2 when using a 3%/1 mm criteria. The lowest gamma analysis pass rate was 90.0%. The independent calculation software had average agreements (max) with the patient and QA plan calculation of 0.2% (2.2%) and −0.1% (2.0%), respectively. Conclusion: We successfully implemented the first GammaPod PSQA program. These results show that the GammaPod can be used to calculate and deliver the predicted dose precisely and accurately. For routine PSQA performed prior to treatments, the independent calculation is recommended as it verifies the accuracy of the planned dose without increasing the risk of losing vacuum due to prolonged waiting times. Copyright 2019 The Authors.
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85076363903&doi=10.1002%2facm2.12778&partnerID=40&md5=5a5b4f4b3abf2c7c80e314bbb0f56d5b; http://hdl.handle.net/10713/11542
- Precise film dosimetry for stereotactic radiosurgery and stereotactic body radiotherapy quality assurance using Gafchromic™ EBT3 films.
- Authors: Wen N, Lu S, Kim J, Qin Y, Huang Y, Zhao B, Liu C, Chetty IJ
- Issue date: 2016 Oct 4
- Patient-specific quality assurance for the delivery of (60)Co intensity modulated radiation therapy subject to a 0.35-T lateral magnetic field.
- Authors: Li HH, Rodriguez VL, Green OL, Hu Y, Kashani R, Wooten HO, Yang D, Mutic S
- Issue date: 2015 Jan 1
- Characterization of a novel 3D printed patient specific phantom for quality assurance in cranial stereotactic radiosurgery applications.
- Authors: Makris DN, Pappas EP, Zoros E, Papanikolaou N, Saenz DL, Kalaitzakis G, Zourari K, Efstathopoulos E, Maris TG, Pappas E
- Issue date: 2019 May 10
- Commissioning and quality assurance of a commercial stereotactic treatment-planning system for extracranial IMRT.
- Authors: Wang L, Li J, Paskalev K, Hoban P, Luo W, Chen L, McNeeley S, Price R, Ma C
- Issue date: 2006 Winter
- Technical Note: Evaluation of plastic scintillator detector for small field stereotactic patient-specific quality assurance.
- Authors: Qin Y, Gardner SJ, Kim J, Huang Y, Wen N, Doemer A, Chetty IJ
- Issue date: 2017 Oct